New ways to develop antibiotics for resistant bacteria.
Innovative technologies to transform antibiotic discovery. Project 4 Infection site-specific amplification of antimicrobial conjugates
This study is working on new treatments that can effectively fight tough bacteria that don't respond to regular antibiotics, aiming to help people with infections caused by these resistant germs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10670196 on NIH RePORTER |
What this research studies
This research focuses on creating innovative antimicrobial agents that specifically target and kill multi-drug resistant Gram-negative bacteria, which are known for their resistance to conventional antibiotics. By engineering long-circulating pro-drug constructs that activate in response to the unique environment of infected tissues, the study aims to improve the effectiveness of treatments. The approach involves designing modular antimicrobial conjugates that combine a targeting agent, a cleavable linker, and a bactericidal payload, allowing for optimization of their activity through extensive testing in laboratory and animal models.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from infections caused by multi-drug resistant Gram-negative bacteria.
Not a fit: Patients with infections caused by non-gram-negative bacteria or those who do not have antibiotic-resistant infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for infections caused by resistant bacteria, improving patient outcomes.
How similar studies have performed: Other research has shown promise in developing targeted antimicrobial therapies, but this specific approach is innovative and addresses a critical unmet need.
Where this research is happening
Cambridge, United States
- Broad Institute, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Hung, Deborah T — Broad Institute, INC.
- Study coordinator: Hung, Deborah T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.